氨氯地平是新型二氢吡啶类钙通道阻滞剂。
Amlodipine (ALDP) is a new kind of calcium channel blocker of dihydropyridine.
结论长效二氢吡啶类钙拮抗剂具有广阔的市场前景。
Conclusion The long acting dihydropyridine calcium antagonist will have wide market prospect.
目的观察新的二氢吡啶类钙拮抗剂拉西地平对大鼠肾性高血压的治疗作用。
AIM To study the therapeutic effects of a novel dihydropyridine calcium antagonist, lacidipine, on renal hypertension of rats.
本发明涉及脂溶性二氢吡啶类钙离子拮抗剂的固体自乳化口服给药系统及其制备方法。
The invention relates to a solid self-emulsifying oral administration system of a fat-soluble dihydropyridine calcium ion antagonist and a preparation method thereof.
目的：阐述二氢吡啶类钙通道阻滞剂的进展和临床应用的历程，评价其疗效与安全性。
OBJECTIVE:To summarize the aspect of clinical usage and progress on the dihydropyridine calcium antagonists, and evaluate its clinical efficacy and safety.
二氢吡啶类钙拮抗剂引起的水肿为局部症状，包括动脉和静脉扩张的不同差异，似与心力衰竭无关。
Edema associated with dihydropyridine calcium antagonists is a localized phenomenon involving varying differences in arteriole and venous dilation and does not appear to be related to heart failure.
二氢吡啶类钙拮抗剂引起的水肿为局部症状，包括动脉和静脉扩张的不同差异，似与心力衰竭无关。
Edema associated with dihydropyridine calcium antagonists is a localized phenomenon involving varying differences in arteriole and venous dilation and does not appear to be related to heart failure.
应用推荐